Clinical trials
Terminated Lung Neoplasms trials in the Netherlands
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2004 | 1 |
| 2008 | 2 |
| 2009 | 2 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2014 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 15 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| European Organisation for Research and Treatment of Cancer - EORTC | 5 |
| Amsterdam UMC, location VUmc | 3 |
| Amgen | 1 |
| Blueprint Medicines Corporation | 1 |
| Galvanize Therapeutics, Inc. | 1 |
| Hoffmann-La Roche | 1 |
| Maastricht Radiation Oncology | 1 |
| Novartis Pharmaceuticals | 1 |
| The Netherlands Cancer Institute | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lung Neoplasms | 15 |
| Carcinoma, Non-Small-Cell Lung | 8 |
| Neoplasms | 3 |
| Adenocarcinoma | 2 |
| Adenocarcinoma of Lung | 2 |
| Carcinoma | 2 |
| Carcinoma, Bronchogenic | 2 |
| Lung Diseases | 2 |
| Neoplasms by Histologic Type | 2 |
| Neoplasms by Site | 2 |
Trials
Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.